unknown-63-1.png

Sentient Synthetics

Business Overview

Active
Operating Status
B2B
Business Model
Software
Offering Type
Description
Sentient is a Technion (Israel Institute of Technology) spin-off, AI-based, digital pathology company, leveraging cutting-edge machine learning to create synthetic pathology datasets for the purpose of overcoming existing data limitations in the field of computational pathology. These synthetic datasets are validated, affordable, thoroughly labeled, and free from privacy concerns. They will enable faster and more accurate training and validation for highly accurate AI algorithms by medical research centers, digital health, pharma, and diagnostics companies, for all cancer tissue types, including the rarer forms.
Sectors

Investors

Investor

Investor Type

Series Preference

Seed, Series A, Series B, Series C

Funding Rounds

Date Announced

Funding Round

Amount Raised

Investors

© 2021 StartupHub.ai. All rights reserved.

You cannot copy content of this page

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database